Filing Details
- Accession Number:
- 0001415889-24-027843
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 16:11:54
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-27 16:11:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Ars Pharmaceuticals Inc. | SPRY | Pharmaceutical Preparations (2834) | 811489190 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1951238 | Justin Chakma | C/O Ars Pharmaceuticals, Inc. 11682 El Camino Real, Suite 120 San Diego CA 92130 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-25 | 32,814 | $14.00 | 203,566 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-26 | 42,186 | $14.05 | 161,380 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-27 | 25,000 | $14.39 | 136,380 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $14.0008, and the range of prices were between $14.00 and $14.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- The weighted average sale price for the transaction reported was $14.0466, and the range of prices were between $13.95 and $14.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Billionaire Hedge Funds
